Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roy M Anderson

Showing results (61-70 of 145) with videos related to

Pageof 15
Sort By:
Plos One|June 23, 2016
Using Clinical Trial Simulators to Analyse the Sources of Variance in Clinical Trials of Novel Therapies for Acute Viral InfectionsCarolin Vegvari, Emilie Cauët, Christoforos Hadjichrysanthou, et al.
Journal of Theoretical Biology|November 5, 2002
Antigen-driven T-cell turnoverChristophe Fraser, Neil M Ferguson, Frank De Wolf, et al.
Alzheimer'S Research & Therapy|June 15, 2020
The dynamics of biomarkers across the clinical spectrum of Alzheimer's diseaseChristoforos Hadjichrysanthou, Stephanie Evans, Sumali Bajaj, et al.
Interface Focus|December 27, 2021
The SARS-CoV-2 pandemic: remaining uncertainties in our understanding of the epidemiology and transmission dynamics of the virus, and challenges to be overcomeRoy M Anderson, Carolin Vegvari, T Déirdre Hollingsworth, et al.
Parasites & Vectors|July 2, 2017
Identifying optimal threshold statistics for elimination of hookworm using a stochastic simulation modelJames E Truscott, Marleen Werkman, James E Wright, et al.
Advances in Parasitology|March 14, 2015
Mathematical inference on helminth egg counts in stool and its applications in mass drug administration programmes to control soil-transmitted helminthiasis in public healthBruno Levecke, Roy M Anderson, Dirk Berkvens, et al.
European Journal of Epidemiology|February 4, 2023
SARS-CoV-2 elicits non-sterilizing immunity and evades vaccine-induced immunity: implications for future vaccination strategiesAnna L Beukenhorst, Clarissa M Koch, Christoforos Hadjichrysanthou, et al.
Parasites & Vectors|July 4, 2015
Cost and cost-effectiveness of soil-transmitted helminth treatment programmes: systematic review and research needsHugo C Turner, James E Truscott, T Déirdre Hollingsworth, et al.
The Lancet. Infectious Diseases|February 22, 2016
Cost-effectiveness of scaling up mass drug administration for the control of soil-transmitted helminths: a comparison of cost function and constant costs analysesHugo C Turner, James E Truscott, Fiona M Fleming, et al.
Parasite Epidemiology and Control|July 19, 2016
Analysis of the population-level impact of co-administering ivermectin with albendazole or mebendazole for the control and elimination of <i>Trichuris trichiura</i>Hugo C Turner, James E Truscott, Alison A Bettis, et al.
Pageof 15

Showing results (61-70 of 145) with videos related to

Sort By:
Pageof 15
Plos One|June 23, 2016
Using Clinical Trial Simulators to Analyse the Sources of Variance in Clinical Trials of Novel Therapies for Acute Viral InfectionsCarolin Vegvari, Emilie Cauët, Christoforos Hadjichrysanthou, et al.
Journal of Theoretical Biology|November 5, 2002
Antigen-driven T-cell turnoverChristophe Fraser, Neil M Ferguson, Frank De Wolf, et al.
Alzheimer'S Research & Therapy|June 15, 2020
The dynamics of biomarkers across the clinical spectrum of Alzheimer's diseaseChristoforos Hadjichrysanthou, Stephanie Evans, Sumali Bajaj, et al.
Interface Focus|December 27, 2021
The SARS-CoV-2 pandemic: remaining uncertainties in our understanding of the epidemiology and transmission dynamics of the virus, and challenges to be overcomeRoy M Anderson, Carolin Vegvari, T Déirdre Hollingsworth, et al.
Parasites & Vectors|July 2, 2017
Identifying optimal threshold statistics for elimination of hookworm using a stochastic simulation modelJames E Truscott, Marleen Werkman, James E Wright, et al.
Advances in Parasitology|March 14, 2015
Mathematical inference on helminth egg counts in stool and its applications in mass drug administration programmes to control soil-transmitted helminthiasis in public healthBruno Levecke, Roy M Anderson, Dirk Berkvens, et al.
European Journal of Epidemiology|February 4, 2023
SARS-CoV-2 elicits non-sterilizing immunity and evades vaccine-induced immunity: implications for future vaccination strategiesAnna L Beukenhorst, Clarissa M Koch, Christoforos Hadjichrysanthou, et al.
Parasites & Vectors|July 4, 2015
Cost and cost-effectiveness of soil-transmitted helminth treatment programmes: systematic review and research needsHugo C Turner, James E Truscott, T Déirdre Hollingsworth, et al.
The Lancet. Infectious Diseases|February 22, 2016
Cost-effectiveness of scaling up mass drug administration for the control of soil-transmitted helminths: a comparison of cost function and constant costs analysesHugo C Turner, James E Truscott, Fiona M Fleming, et al.
Parasite Epidemiology and Control|July 19, 2016
Analysis of the population-level impact of co-administering ivermectin with albendazole or mebendazole for the control and elimination of <i>Trichuris trichiura</i>Hugo C Turner, James E Truscott, Alison A Bettis, et al.
Pageof 15